Clinical Efficacy of Tofacitinib in Treating Granulomatous Reaction After Mesotherapy: A Case Series Analysis
Open Access
- 19 March 2026
- journal article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (3) , e70799
Abstract
Background: Mesotherapy, a widely utilized minimally invasive cosmetic procedure, carries potential risks of adverse reactions due to non‐standardized protocols and overuse. Delayed granulomatous reactions represent a chronic complication, imposing significant physical and psychological burdens on patients. Objective: This case series aims to evaluate the efficacy and safety of tofacitinib in managing non‐infectious granulomatous reactions following mesotherapy. Methods: This retrospective analysis included six patients diagnosed with non‐infectious granulomatous reactions post‐mesotherapy, treated at Peking Union Medical College Hospital between October 2021 and April 2025. All patients received oral tofacitinib. Clinical outcomes, treatment regimens, and safety profiles were assessed. Results: All six patients demonstrated significant improvement in skin lesion severity, with no treatment‐related adverse events observed during follow‐up. Conclusion: Oral tofacitinib exhibits promising clinical efficacy and a favorable safety profile for non‐infectious granulomatous reactions induced by mesotherapy, positioning it as a viable therapeutic option during the inflammatory phase.Keywords
This publication has 23 references indexed in Scilit:
- Hyperbaric oxygen therapy acts as an alternative method in treating injection‐induced nodulesJournal of Cosmetic Dermatology, 2021
- An Update on Facial Skin Rejuvenation Effectiveness of Mesotherapy EBM VJournal of Craniofacial Surgery, 2021
- Mesotherapy: From Historical Notes to Scientific Evidence and Future ProspectsThe Scientific World Journal, 2020
- Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disordersJournal of the American Academy of Dermatology, 2020
- El costo de la belleza: Comunicación de seis casos clínicos con infección por micobacterias atípicas secundario a inyecciones intradérmicas y reacción a un dermoimplante de origen desconocidoRevista chilena de infectología, 2019
- Mesotherapy: Safety profile and management of complicationsJournal of Cosmetic Dermatology, 2019
- Cutaneous foreign body granulomas associated with lipolytic cocktail: Who is the enemy, mesotherapy or drugs injected?Journal of Cosmetic and Laser Therapy, 2017
- Mesotherapy, Microneedling, and Chemical PeelsClinics in Plastic Surgery, 2016
- Foreign Body Granulomas after the Use of Dermal Fillers: Pathophysiology, Clinical Appearance, Histologic Features, and TreatmentArchives of Plastic Surgery, 2015
- Intralesional Infliximab in Noninfectious Cutaneous Granulomas: Three Cases of Necrobiosis LipoidicaDermatology, 2011